| Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy S Bose, P Saha, B Chatterjee, AK Srivastava Seminars in Cancer Biology 86, 568-579, 2022 | 31 | 2022 |
| MicroRNAs: as critical regulators of tumor-associated macrophages B Chatterjee, P Saha, S Bose, D Shukla, N Chatterjee, S Kumar, ... International journal of molecular sciences 21 (19), 7117, 2020 | 23 | 2020 |
| MicroRNAs: Key modulators of inflammation-associated diseases B Chatterjee, M Sarkar, S Bose, MT Alam, AA Chaudhary, AK Dixit, ... Seminars in Cell & Developmental Biology 154, 364-373, 2024 | 16 | 2024 |
| Jeopardy of COVID-19: rechecking the perks of phytotherapeutic interventions P Saha, S Bose, AK Srivastava, AA Chaudhary, R Lall, S Prasad Molecules 26 (22), 6783, 2021 | 9 | 2021 |
| MiRNA-3163 limits ovarian cancer stem-like cells via targeting SOX-2 transcription factor B Chatterjee, S Bose, R Singh, AK Dixit, L Puia, AK Srivastava Non-coding RNA Research, 2024 | 2 | 2024 |
| Expression Profile, Molecular Association, and Clinical Significance of POLD4 in Glioblastoma MT Alam, MS Ali, H Goel, J Singh, B Chatterjee, S Bose, V Hadda, ... Cellular and Molecular Neurobiology 43 (7), 3753-3765, 2023 | 1 | 2023 |
| Inhibition of DNA polymerase eta-mediated translesion DNA synthesis by small molecule sensitizes ovarian cancer stem-like cells to chemotherapy A Srivastava, S Bose, P Saha, MT Alam, B Chatterjee, M Sarkar, A Dixit, ... | 1 | 2023 |
| Clinical potential of nanotechnlogy as smart therapeutics: A step toward targeted drug delivery P Saha, S Bose, MN Javed, AK Srivastava Advances in Nanotechnology-Based Drug Delivery Systems, 133-154, 2022 | 1 | 2022 |
| 2019 Index IEEE Journal of the Electron Devices Society Vol. 7 MM Adnan, A Afzalian, J Ahn, Y Ahn, R Aiba, S Alajlouni, MA Alam, ... IEEE Journal of the Electron Devices Society 7 (1), 2019 | | 2019 |
